Dr Haymanot Y Gebre, MD | |
G3230 Beecher Rd Ste 2, Flint, MI 48532 | |
(810) 342-5800 | |
(810) 342-5810 |
Full Name | Dr Haymanot Y Gebre |
---|---|
Gender | Female |
Speciality | Hospitalist |
Experience | 17 Years |
Location | G3230 Beecher Rd Ste 2, Flint, Michigan |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1013370394 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | 4301110280 (Michigan) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Medstar Southern Maryland Hospital Center | Clinton, MD | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Medstar Medical Group Ii Llc | 0547413825 | 1776 |
News Archive
Sinks situated next to patient toilets in hospital rooms may be reservoirs for Klebsiella pneumoniae carbapenemase, increasing the risk of dangerous germ transmission, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented their data at the American Society of Clinical Oncology Annual Meeting.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.
› Verified 9 days ago
Entity Name | Kaiser Foundation Health Plan Of The Mid-atlantic States,inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1952461816 PECOS PAC ID: 3779495858 Enrollment ID: O20040105000308 |
News Archive
Sinks situated next to patient toilets in hospital rooms may be reservoirs for Klebsiella pneumoniae carbapenemase, increasing the risk of dangerous germ transmission, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented their data at the American Society of Clinical Oncology Annual Meeting.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.
› Verified 9 days ago
Entity Name | Medstar Medical Group Ii Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1184046187 PECOS PAC ID: 0547413825 Enrollment ID: O20130117000415 |
News Archive
Sinks situated next to patient toilets in hospital rooms may be reservoirs for Klebsiella pneumoniae carbapenemase, increasing the risk of dangerous germ transmission, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented their data at the American Society of Clinical Oncology Annual Meeting.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Haymanot Y Gebre, MD G3230 Beecher Rd Ste 2, Flint, MI 48532-3604 Ph: (810) 342-5800 | Dr Haymanot Y Gebre, MD G3230 Beecher Rd Ste 2, Flint, MI 48532 Ph: (810) 342-5800 |
News Archive
Sinks situated next to patient toilets in hospital rooms may be reservoirs for Klebsiella pneumoniae carbapenemase, increasing the risk of dangerous germ transmission, according to new research published in the American Journal of Infection Control, the journal of the Association for Professionals in Infection Control and Epidemiology.
APP Pharmaceuticals, Inc., a wholly owned subsidiary of Fresenius Kabi Pharmaceuticals Holding, Inc., announced today that it has received approval from the U.S. Food and Drug Administration (FDA) to market preservative-free Methotrexate Injection, USP. APP currently manufactures Methotrexate Injection with preservative.
A new study shows that a large majority of patients who present with advanced colorectal cancer that has spread to other organs (stage IV) don't require immediate surgery to remove the primary tumor in the colon. Researchers from Memorial Sloan-Kettering Cancer Center (MSKCC) presented their data at the American Society of Clinical Oncology Annual Meeting.
Solta Medical, Inc. (Nasdaq: SLTM) is proud to celebrate the launch of the new Thermage CPT and Fraxel re:store Dual systems with the kick off of the illumiNATION tour (www.illumiNATIONtour.com). Starting September 14 and continuing through November, the illumiNATION tour is bringing the latest breakthroughs in Thermage(R) and Fraxel(R) systems directly to physicians in over 20 cities across the U.S. and 11 cities in Europe.
The U.S. Food and Drug Administration today released a warning letter issued to Zhejiang Huahai Pharmaceutical Co. Ltd. (ZHP), in Linhai, Taizhou Zhejiang China, the manufacturer of the active pharmaceutical ingredient (API) found in valsartan that is the subject of an ongoing FDA investigation into probable cancer-causing impurities in certain commonly prescribed heart medicines.
› Verified 9 days ago
Vidya Sagar Kollu, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: G3230 Beecher Rd, Suite 2, Flint, MI 48532 Phone: 810-342-5800 Fax: 810-342-5810 | |
Dr. Mohamad Monir Khoulani, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5080 Villa Linde Pkwy, Unit 4, Flint, MI 48532 Phone: 810-720-5440 Fax: 810-720-4670 | |
Russell Diponio, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4444 W Bristol Rd Ste 150, Flint, MI 48507 Phone: 810-230-9500 Fax: 810-230-0169 | |
Muhammad Bakleh, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5040 Villa Linde Pkwy, Flint, MI 48532 Phone: 810-230-0788 | |
Dr. Donald J Hardman, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 3499 S Linden Rd Ste 2, Flint, MI 48507 Phone: 810-820-8121 Fax: 810-820-8335 | |
Hameem Changezi, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 5084 Villa Linde Pkwy, Suite 6, Flint, MI 48532 Phone: 810-600-3399 Fax: 810-600-3398 |